Abstract
A wide range of evidence shows that acetylcholinesterase (AChE) inhibitors can
Keywords: donepezil hydrochloride, acetylcholinesterase inhibitors, alzheimer s disease, AChE inhibitors, cortical cholinergic neurotransmission, hepatotxic liability, physostigmine, cholineric enhancement therapy, ACh releasers, M1 M3 Receptor agonists, nicotinic agonists, velnacrine, amiridine, eptastigmine, galanthamine, rivastigmine, metrifonate, huperzine A, donepezil hydrocloride, anti AChE Activity, n alkyl analogs, molecular modeling, receptor dependent docking, crystal structure, BuChE, Brain acetylcholine concentrations, TAK 147, anti inflammatory agents, alzheimer s disease treatment, estrogen replacement therapy, anti oxidants, anti amyloid, galanin receptor antagonist
Current Medicinal Chemistry
Title: Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors
Volume: 7 Issue: 3
Author(s): Hachiro Sugimoto, Yoshiharu Yamanish, Youichi Iimura and Yoshiyuki Kawakami
Affiliation:
Keywords: donepezil hydrochloride, acetylcholinesterase inhibitors, alzheimer s disease, AChE inhibitors, cortical cholinergic neurotransmission, hepatotxic liability, physostigmine, cholineric enhancement therapy, ACh releasers, M1 M3 Receptor agonists, nicotinic agonists, velnacrine, amiridine, eptastigmine, galanthamine, rivastigmine, metrifonate, huperzine A, donepezil hydrocloride, anti AChE Activity, n alkyl analogs, molecular modeling, receptor dependent docking, crystal structure, BuChE, Brain acetylcholine concentrations, TAK 147, anti inflammatory agents, alzheimer s disease treatment, estrogen replacement therapy, anti oxidants, anti amyloid, galanin receptor antagonist
Abstract: A wide range of evidence shows that acetylcholinesterase (AChE) inhibitors can
Export Options
About this article
Cite this article as:
Sugimoto Hachiro, Yamanish Yoshiharu, Iimura Youichi and Kawakami Yoshiyuki, Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors, Current Medicinal Chemistry 2000; 7 (3) . https://dx.doi.org/10.2174/0929867003375191
DOI https://dx.doi.org/10.2174/0929867003375191 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Is there a Need for Safety Monitoring Guidelines for Antidepressant Treatment?)
Current Drug Safety TRAIL: A Sword for Killing Tumors
Current Medicinal Chemistry HIF-1α Deficiency Perturbs T and B Cell Functions
Current Pharmaceutical Design Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide
Protein & Peptide Letters Motor Recovery after Chronic Spinal Cord Transection in Rats: A Proof-of-Concept Study Evaluating a Combined Strategy
CNS & Neurological Disorders - Drug Targets Safer, Greener, and More Facile Alternatives for Synthesis with Organic Azides
Current Organic Synthesis Mechanism-Based Inhibitors from Phytomedicine: Risks of Hepatotoxicity and their Potential Hepatotoxic Substructures
Current Drug Metabolism Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Current Topics in Medicinal Chemistry Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping
Current Molecular Pharmacology The Assessment of Attenuated Psychotic Symptoms in Adolescents: Concepts, Practical Approaches and Prediction of Risk
Adolescent Psychiatry Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
Current Pharmaceutical Design Psychosocial Predictors of Relapse Among Patients with Alcohol Problems
Current Drug Abuse Reviews Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure
Current Pharmaceutical Biotechnology In Vitro Metabolism Studies of New Adenosine A Receptor Antagonists
Drug Metabolism Letters In Search of Novel AMPA Potentiators
Recent Patents on CNS Drug Discovery (Discontinued) Kinetic and Structural Determinants for GABA-A Receptor Potentiation by Neuroactive Steroids
Current Neuropharmacology Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Natural Resins and Bioactive Natural Products thereof as Potential Anitimicrobial Agents
Current Pharmaceutical Design Shut-Down of Translation, a Global Neuronal Stress Response:Mechanisms and Pathological Relevance
Current Pharmaceutical Design